Travere Therapeutics, Inc. is in its Venus mahadasha (8 Nov 2013 to 8 Nov 2033), Saturn antardasha (8 Sep 2026 to 8 Nov 2029) and Saturn pratyantar (8 Sep 2026 to 10 Mar 2027).
Next: pratyantar Mercury from 10 Mar 2027; antardasha Mercury from 8 Nov 2029; mahadasha Sun from 8 Nov 2033.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Tula (Libra) | 22°34′ | 1st | Vishakha 1 |
| Moon | Simha (Leo) | 11°26′ | 11th | Magha 4 |
| Mars | Vrishchika (Scorpio) | 29°36′ | 2nd | Jyeshtha 4 |
| Mercury (R) | Vrishchika (Scorpio) | 10°05′ | 2nd | Anuradha 3 |
| Jupiter (R) | Vrishabha (Taurus) | 20°23′ | 8th | Rohini 4 |
| Venus | Kanya (Virgo) | 19°26′ | 12th | Hasta 3 |
| Saturn | Tula (Libra) | 10°02′ | 1st | Swati 2 |
| Rahu | Vrishchika (Scorpio) | 2°24′ | 2nd | Vishakha 4 |
| Ketu | Vrishabha (Taurus) | 2°24′ | 8th | Krittika 2 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how TVTX moved in each period against the S&P 500, transits, fundamentals and news.